Related Experiment Video

Updated: Jun 3, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Melanoma's deadly march to the brain: by what route, and can it be stopped?

Megan Othus, James Moon, Kim Margolin

    Cancer
    |April 8, 2011
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
    07:43

    Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

    Published on: February 8, 2017

    A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
    07:41

    A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

    Published on: March 8, 2022

    Related Experiment Videos

    Last Updated: Jun 3, 2026

    A 3D Organotypic Melanoma Spheroid Skin Model
    08:49

    A 3D Organotypic Melanoma Spheroid Skin Model

    Published on: May 18, 2018

    Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
    07:43

    Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

    Published on: February 8, 2017

    A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
    07:41

    A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

    Published on: March 8, 2022

    Related Concept Videos

    Skin Cancer01:30

    Skin Cancer

    Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
    Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
    Metastasis02:30

    Metastasis

    Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
    Epithelial-to-Mesenchymal Transition
    The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

    Articles linked to this work by shared authors, journal, and citation graph.

    Induction and consolidation atezolizumab with stereotactic body radiation therapy versus radiation alone in high-risk, early-stage non-small-cell lung cancer (SWOG/NRG S1914): a multicentre, open-label, superiority, phase 3, randomised controlled trial.

    Lancet (London, England)·2026

    Prognostic impact of age and MDS-associated mutations in NPM1-mutated AML.

    Blood neoplasia·2026

    Vutrisiran Treatment and Changes in Cardiac Parameters and Amyloid Burden Assessed by Cardiovascular MRI.

    JAMA cardiology·2026

    Realistic anatomical model reconstruction and high-fidelity flow computation in stented coronary arteries for the analysis of in-stent thrombosis.

    Frontiers in cardiovascular medicine·2026

    Prevalence and Determinants of Asymmetric Septal Hypertrophy (ASH) in Diseases of Left Ventricular Hypertrophy (LVH).

    European heart journal. Cardiovascular Imaging·2026

    A phase II basket trial of DART SWOG S1609: the salivary gland tumor cohort.

    Therapeutic advances in medical oncology·2026

    Long-term outcomes and patterns of failure in patients with thymic malignancies treated with surgery and radiation therapy.

    Cancer·2026

    GPRC5D-targeting bispecific and trispecific antibodies in multiple myeloma: Current evidence and emerging strategies.

    Cancer·2026

    Adjuvant CDK4/6 inhibitors in early-stage breast cancer: Clinical evidence and considerations for risk stratification and treatment selection.

    Cancer·2026

    The burden of male breast cancer (MBC) in the GBD Central, Eastern, and Western Europe Regions from 1990 to 2023: Results from the Global Burden of Disease Study 2023.

    Cancer·2026

    Racial differences in multiple myeloma survival: Associations with stem cell transplantation, insurance, and Medicaid expansion.

    Cancer·2026

    Cancer statistics for Asian American, Native Hawaiian, and Pacific Islander people, 2026.

    Cancer·2026

    TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment.

    The Journal of experimental medicine·2026

    Activation of PP2A-B56a leads to aberrant EGFR signaling and proliferative phenotypes in PDAC.

    Molecular cancer therapeutics·2026

    Toward Fit-for-Purpose Data for Drug Assessment in Non-small Cell Lung Cancer: A Core Dataset.

    Clinical pharmacology and therapeutics·2026

    Regulation of the lncRNA NEAT1 by p53-ΔNp63 crosstalk modulates the DNA damage response and therapeutic efficacy in HNSCC.

    Molecular oncology·2026

    Payload-Free [89Zr]Zr-DFO*-sq-Enfortumab ImmunoPET for Imaging Nectin-4 Expression in Bladder Cancer.

    Molecular pharmaceutics·2026

    Preclinical Evaluation of [68Ga]Ga-CS03 as a Novel GPC3-Targeted Probe for Imaging GPC3 in Hepatocellular Carcinoma Models.

    Molecular pharmaceutics·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us